Bradykinin and angiotensin-converting enzyme in serum of patients with diabetic retinopathy and the prognosis of diabetic macular edema development (pilot study)
Open Access
- 19 August 2021
- journal article
- research article
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 67 (4) , 13-19
Abstract
BACKGROUND. Diabetic macular edema (DME) is a microvascular complication of diabetic retinopathy. One of the key roles in the pathogenesis of DME may belong to the components of rennin-angiotensin and kallikrein-kinin systems: bradykinin (Bk) and angiotensin-converting enzyme (ACE).PURPOSE. To determine the Bk and ACE concentration and ACE activity in serum of patients with proliferative diabetic retinopathy (PDR) and to estimate the significance of these parameters for the early diagnostic and prognosis of DMO.MATERIALS AND METHODS. Serum was collected from the 2 groups of patients with II type diabetes. Group I (n=9) had DME, group II (n=27) had PDR without DME. Control group (n=14) consisted of adult volonteers without diabetes and ophthalmic diseases. Concentration of Bk and ACE was measured using ELISA kits, ACE activity was determined enzymatically with specific fluorogenic substrate.RESULTS. Concentration of Bk in serum of patients without DME did not differ from one in controls (12,00 (9,70; 12,40) pg/ml) while all patients with DME had Bk level of 14,69 (13,68; 16,78) pg/ml that was significantly higher (pCONCLUSION. Patients with DME have increased Bk concentration along with nearly normal ACE concentration that indicate predominance of Bk synthesis over its degradation that may lead to the DME development. The Bk/ACE ratio decrease in patients with uncomplicated PDR and increase significantly in ones with DME. It means that determination of Bk in serum of patients with PDR may be used for the prediction of DME development. The Bk/ACE concentrations ratio may be even more informative.Keywords
This publication has 19 references indexed in Scilit:
- The Role of Plasma Kallikrein–Kinin Pathway in the Development of Diabetic Retinopathy: Pathophysiology and Therapeutic ApproachesSeminars in Ophthalmology, 2016
- Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular EdemaDiabetes, 2015
- Plasma kallikrein-kinin system and diabetic retinopathyBiological Chemistry, 2013
- Role of plasma kallikrein in diabetes and metabolismThrombosis and Haemostasis, 2013
- Alternative pathways in the development of diabetic retinopathy: the renin‐angiotensin and kallikrein‐kinin systemsClinical and Experimental Optometry, 2012
- Kinin B1receptor upregulation by angiotensin II and endothelin-1 in rat vascular smooth muscle cells: receptors and mechanismsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Plasma and Aqueous Humor Angiotensin-Converting Enzyme Levels in Patients with Diabetic RetinopathyCurrent Eye Research, 2010
- The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: The Twenty-five-Year Incidence of Macular Edema in Persons with Type 1 DiabetesOphthalmology, 2009
- Simultaneous Determination of ACE Activity with 2 Substrates Provides Information on the Status of Somatic ACE and Allows Detection of Inhibitors in Human BloodJournal of Cardiovascular Pharmacology, 2008
- Canine pulmonary angiotensin-converting enzyme. Physicochemical, catalytic and immunological propertiesBiochimica et Biophysica Acta (BBA) - Enzymology, 1978